Just wrapped up nearly 2 hours on the EG conferenc
Post# of 148337
(Total Views: 438)
Posted On: 10/13/2021 3:06:12 PM
Just wrapped up nearly 2 hours on the EG conference and while there were no HUGE news splashes, it was informative enough for me.
NP was a little more cautionary and reserved, that is a good thing. Dr. Recknor was positive and as always, very sober and matter of fact in his comments, Dr. Kelly was straightforward as usual and Dr. Ray sounded confident.
Brazil update not what we would like, but reality can be a blunt instrument when you want fireworks. Sounds like in the next week, there will be an update on CD16 and CD17.
Sounded to me like Dr. Recknor was solving the lack of data from Amarex by going to the trial sites and assembling the missing links in the data.
The "Special Financing" we have seen (and some complain they were not offered) will be used to get the necessary funds to carry us into 2022.
Overall, today should help those who had concerns about Amarex causing us to fail or at the very least suffer crippling setbacks.
13d'ers will now go wild....at least until the hammer drops!
NP was a little more cautionary and reserved, that is a good thing. Dr. Recknor was positive and as always, very sober and matter of fact in his comments, Dr. Kelly was straightforward as usual and Dr. Ray sounded confident.
Brazil update not what we would like, but reality can be a blunt instrument when you want fireworks. Sounds like in the next week, there will be an update on CD16 and CD17.
Sounded to me like Dr. Recknor was solving the lack of data from Amarex by going to the trial sites and assembling the missing links in the data.
The "Special Financing" we have seen (and some complain they were not offered) will be used to get the necessary funds to carry us into 2022.
Overall, today should help those who had concerns about Amarex causing us to fail or at the very least suffer crippling setbacks.
13d'ers will now go wild....at least until the hammer drops!
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼